NIH-funded research R01 grant

Using ketamine to help mothers with depression and pain after cesarean delivery

Official title: Ketamine to reduce postpartum depression and pain after cesarean delivery

Funded at University of Pittsburgh at Pittsburgh · NIH-11086759 · Data updated 2026-11-12

This study is looking at how ketamine can help new moms feel better by reducing postpartum depression and pain after a cesarean delivery, and it aims to find the best dose to improve their mood and manage pain safely.

More Depression research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJuly 1, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$538,385
NIH project number5R01MH134538-03
Project IDNIH-11086759 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are mothers who have recently undergone a cesarean delivery and are experiencing symptoms of postpartum depression or pain.

Less likely to help

Patients who have not had a cesarean delivery or those who do not experience postpartum depression or pain may not benefit from this research.

What this research studies

This research investigates the use of ketamine to alleviate postpartum depression and pain in mothers who have undergone cesarean delivery. The study aims to determine the optimal dosage of ketamine and its effects on pain management and mood improvement in this specific population. By focusing on the unique challenges faced by new mothers, the research seeks to provide a more effective treatment option that considers both pain relief and mental health. Participants will be monitored for side effects and overall recovery to ensure the safety and efficacy of the treatment.

Why it matters

Potential benefit: If successful, this research could provide a new treatment option that significantly reduces postpartum depression and pain for mothers after cesarean delivery.

How similar studies have gone: While there have been limited studies on ketamine for postpartum conditions, this research aims to fill a significant knowledge gap and explore its effects specifically in postpartum women after cesarean delivery.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Lim, Grace — University of Pittsburgh at Pittsburgh
  • Study coordinator: Lim, Grace

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.